On October 1, 2025, Stryker announced the opening of a new 140,000-square-foot research and development center in Bangalore, India. This significant investment strengthens the company's innovation footprint globally. The facility is specifically designed to accelerate initiatives in artificial intelligence (AI) and robotics.
The new R&D hub underscores Stryker's commitment to leveraging advanced technologies to drive future growth and enhance its product offerings. By focusing on AI and robotics, the company aims to develop next-generation medical technologies that improve patient and healthcare outcomes. This strategic expansion in India taps into a growing talent pool and innovation ecosystem.
This operational milestone is expected to contribute to Stryker's long-term competitive advantage in the medical technology industry. The center will play a crucial role in developing innovative solutions across Stryker's MedSurg, Neurotechnology, and Orthopaedics segments. The investment reflects confidence in the potential of AI and robotics to transform healthcare.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.